Results

Total Results: 1,636 records

Showing results for "treating".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
    June 01, 2016 - Treating Infantile Hemangiomas in Children Treating Infantile Hemangiomas in Children A Review of … treatment � The cost of the treatment Ask your child’s health care professional � Do you recommend treating
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-substitute_0.pdf
    October 03, 2019 - Skin Substitutes for Treating Chronic Wounds Evidence-based Practice Center Technical Brief Protocol … Project Title: Skin Substitutes for Treating Chronic Wounds Initial publication date: November 27 … Are there situations in which a clinician should not use a skin substitute when treating chronic wounds … analyses published since 2012, the publications date of the evidence report “Skin Substitutes for Treating … Skin substitutes for treating chronic wounds. Final report.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
    May 01, 2017 - Treating and Preventing C. difficile Infections Treating and Preventing C. difficile Infections A
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
    August 01, 2016 - Treating Disruptive Behavior Disorders in Children and Teens Treating Disruptive Behavior Disorders
  5. effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy Source: https:/ … Effectiveness Review Disposition of Comments Report Research Review Title: Preventing Complications and Treating … Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy Source: https:/ … Effectiveness Review Disposition of Comments Report Research Review Title: Preventing Complications and Treating … Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy.
  7. effectivehealthcare.ahrq.gov/products/binge-eating/consumer
  8. effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/consumer
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_consumer.pdf
    May 01, 2016 - Treating Binge-Eating Disorder. … A Review of Evidence for Adults Treating Binge-Eating Disorder A Review of the Research for Adults
  10. effectivehealthcare.ahrq.gov/products/infantile-hemangioma/consumer
  11. effectivehealthcare.ahrq.gov/products/c-difficile-update/consumer
  12. effectivehealthcare.ahrq.gov/products/skin-substitutes/protocol
  13. effectivehealthcare.ahrq.gov/products/diabetic-neuropathy/research-2017
  14. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - , as the first IFN-free treatment option with RBV for treating genotypes 2 or 3. … or 6 infection; ledipasvir/sofosbuvir for treating HCV genotype 1 infection, daclatasvir for treating … Recommendations for testing, managing, and treating hepatitis C. … HS1730 - Ledipasvir for treating chronic hepatitis C infection. 2014 Jun 19. 76. … HS1730 - Ledipasvir for treating chronic hepatitis C infection. 2014 Jul 11. 79.
  15. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
    December 01, 2015 - ; Harvoni for treating HCV genotype 1 or 4 infection, Viekira Pak for treating chronic genotype 1 or … 4 infection, and Daklinza for treating genotype 1, 2, 3, 4, 5, or 6 infection. … HS1730 - Ledipasvir for treating chronic hepatitis C infection. 2014 Jun 19. 88. … HS1730 - Ledipasvir for treating chronic hepatitis C infection. 2014 Jun 17. 89. … HS1730 - Ledipasvir for treating chronic hepatitis C infection. 2014 Jun 17.
  16. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
    January 28, 2016 - Experts also deemed seven drugs for treating chronic HCV infection as having high-impact potential: … To date, FDA has approved DAAs for treating patients who are infected with HCV genotypes 1 through … Grazoprevir/elbasvir is being evaluated in several phase II and III trials for treating chronic HCV … It was approved in combination with RBV for treating chronic HCV genotype 2 or 3 infection. … Recommendations for testing, managing, and treating hepatitis C.
  17. effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
  18. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - This report addresses two topics, both off-label pharmacotherapies with potential use for treating … are pursuing labeling for treating BPD or MDD, and third-party payers generally do not reimburse its … Several ongoing, large clinical trials are investigating ketamine’s efficacy for treating MDD, BPD, … MDD and are used as monotherapies or in combination regimens.54-56 For treating BPD, anticonvulsants … Glutamatergic modulators: the future of treating mood disorders?
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
    November 01, 2016 - Pharmacological interventions: Nonsteroidal anti- inflammatory drugs (NSAIDs) may be effective in treating … low back pain (see Table 2) �� Nonpharmacological interventions: Superficial heat is effective in treating … Exercise, acupuncture, spinal manipulation, and multidisciplinary rehabilitationa are effective in treating … moderate SOE). �� Pharmacological interventions: NSAIDs, opioids, and duloxetine are effective in treating … their low back pain �� The limited evidence for the benefits of opioids in treating chronic low back
  20. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Five phase III trials on secukinumab for treating AS are ongoing. … In January 2015, secukinumab was approved for treating plaque psoriasis. … If approved for treating AS, secukinumab would likely be covered for treating patients with active … Four phase III trials on secukinumab for treating PsA are ongoing. … treating PsA are expected in 2015.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: